For: | Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues. World J Gastroenterol 2012; 18(48): 7149-7157 [PMID: 23326119 DOI: 10.3748/wjg.v18.i48.7149] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i48/7149.htm |
Number | Citing Articles |
1 |
Ying Cai, Ning Wang, Xiaomei Wu, Kai Zheng, Yan Li. Compensatory variances of drug-induced hepatitis B virus YMDD mutations. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3003-x
|
2 |
Byung Gyu Kim, Seok Won Jung, Eun Hye Kim, Jae Hee Kim, Ju Hwan Park, Shi Jung Sung, Bo Ryung Park, Min‐Ho Kim, Chang Jae Kim, Byung Uk Lee, Jae Ho Park, In Du Jeong, Sung‐Jo Bang, Jung Woo Shin, Neung Hwa Park. Tenofovir‐based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir. Journal of Gastroenterology and Hepatology 2015; 30(10): 1514 doi: 10.1111/jgh.12993
|
3 |
Mei Sun, Guolei Tan, Jinyun Song, Jianfang Wang, Xuping Wu. Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B. Clinics and Research in Hepatology and Gastroenterology 2016; 40(5): 590 doi: 10.1016/j.clinre.2016.02.005
|
4 |
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
|
5 |
Thomas Michler, Stefanie Große, Stefan Mockenhaupt, Natalie Röder, Ferdinand Stückler, Bettina Knapp, Chunkyu Ko, Mathias Heikenwalder, Ulrike Protzer, Dirk Grimm. Blocking sense‐strand activity improves potency, safety and specificity of anti‐hepatitis B virus short hairpin RNA. EMBO Molecular Medicine 2016; 8(9): 1082 doi: 10.15252/emmm.201506172
|
6 |
Wenhao Hua, Guanbin Zhang, Shujun Guo, Weijie Li, Lanhua Sun, Guangxin Xiang. Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection. The Brazilian Journal of Infectious Diseases 2015; 19(3): 291 doi: 10.1016/j.bjid.2015.03.012
|
7 |
Yan-hui Sun, Xiao-yuan Zhang, Wei-qun Xie, Guang-jian Liu, Xi-xin He, Ya-li Huang, Guang-xian Zhang, Jian Wang, Zao-yuan Kuang, Ren Zhang. Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen. Journal of Ethnopharmacology 2016; 193: 133 doi: 10.1016/j.jep.2016.08.007
|
8 |
Wen-Chun Liu, Chih-Peng Lin, Chun-Pei Cheng, Cheng-Hsun Ho, Kuo-Lun Lan, Ji-Hong Cheng, Chia-Jui Yen, Pin-Nan Cheng, I-Chin Wu, I-Chen Li, Bill Chia-Han Chang, Vincent S. Tseng, Yen-Cheng Chiu, Ting-Tsung Chang. Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus. Hepatology International 2016; 10(1): 147 doi: 10.1007/s12072-015-9645-x
|
9 |
Minoo Motahar, Seyed AliMohammad Arabzadeh, Hamidreza Mollaei, Zahra Iranmanesh, Najmeh Nikpour, Fariba Soleimani. Evaluation of HBV resistance to tenofovir in patients with chronic hepatitis B using ZNA probe assay in Kerman, southeast of Iran. Asian Pacific Journal of Tropical Disease 2016; 6(7): 513 doi: 10.1016/S2222-1808(16)61079-4
|
10 |
Xian-Hua Xu, Gai-Li Li, Yang Qin, Qiang Li, Fa-Qun He, Jin-Ye Li, Quan-Rong Pan, Jie-Yin Deng. Entecavir plus adefovir rescue therapy for chronic hepatitis B patients after multiple treatment failures in real-life practice. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-162
|
11 |
Xiaoqiang Chai, Yanan Han, Jian Yang, Xianxian Zhao, Yewang Liu, Xugang Hou, Yiheng Tang, Shirong Zhao, Xiao Li. Identification of the transcriptional regulators by expression profiling infected with hepatitis B virus. Clinics and Research in Hepatology and Gastroenterology 2016; 40(1): 57 doi: 10.1016/j.clinre.2015.04.005
|
12 |
Seiichi Sato, Kai Li, Takeshi Kameyama, Takaya Hayashi, Yuji Ishida, Shuko Murakami, Tsunamasa Watanabe, Sayuki Iijima, Yu Sakurai, Koichi Watashi, Susumu Tsutsumi, Yusuke Sato, Hidetaka Akita, Takaji Wakita, Charles M. Rice, Hideyoshi Harashima, Michinori Kohara, Yasuhito Tanaka, Akinori Takaoka. The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus. Immunity 2015; 42(1): 123 doi: 10.1016/j.immuni.2014.12.016
|
13 |
Sanae Hayashi, Shuko Murakami, Katsumi Omagari, Takeshi Matsui, Etsuko Iio, Masanori Isogawa, Tsunamasa Watanabe, Yoshiyasu Karino, Yasuhito Tanaka. Characterization of novel entecavir resistance mutations. Journal of Hepatology 2015; 63(3): 546 doi: 10.1016/j.jhep.2015.03.020
|
14 |
Muneyoshi Kimura, Sagar Kothari, Wajiha Gohir, Jose F. Camargo, Shahid Husain, Graeme N. Forrest. MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets. Clinical Microbiology Reviews 2023; 36(4) doi: 10.1128/cmr.00015-23
|
15 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
16 |
Wenjie Li, Fei Cao, Juan Li, Zhixin Wang, Yu Ren, Zheyong Liang, Peijun Liu. Simvastatin exerts anti-hepatitis B virus activity by inhibiting expression of minichromosome maintenance protein 7 in HepG2.2.15 cells. Molecular Medicine Reports 2016; 14(6): 5334 doi: 10.3892/mmr.2016.5868
|